Reported Reactions

Adverse event reports that FDA received

  • Search
  • Watch list

February 2011 adverse event reports that FDA received in the month

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on . The data have the reports that FDA received through .

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.

Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on .

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports received

In February 2011, FDA received 38,469 drug adverse event reports. In February 2010, FDA received 31,674.

In February 2011, FDA received 29,578 medical device reports. In February 2010, FDA received 24,416.

By drug reports received, February 2011 was number 12 of the 12 months of 2011. FDA received 41,796 drug reports a month on average in the 12 months before February 2011.

Receive date

A month is the month in which FDA first received the report, not the month of the event. A report about an event of an earlier year is in the month in which it came to FDA.

Data version

FAERS release of 29 Oct 2026. MAUDE release of 23 Oct 2026.

Drug reports, three years

Drug reports that FDA received each month, 36 months to February 2011
050,000100,000200920102011

Drugs in the reports

The table has the 88 drug pages with 100 or more reports in February 2011. The rows are in order of name. A drug page with fewer reports is not in the table.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Drugs that the reports of February 2011 name as a suspect product, in order of name
DrugReports in the month
Accutane252
Acetaminophen296
Aclasta137
Aleve220
Alprazolam119
Amnesteem1,046
Arixtra123
Aspirin122
Avandamet129
Avandia808
Avastin135
Avonex618
Bevacizumab161
BOTOX Cosmetic1,245
Botoxa188
Carboplatin156
Celebrex111
Chantix485
Cimzia114
Cisplatin195
Claravis235
Clozaril123
Crestor176
Cyclophosphamide355
Cymbalta142
Desvenlafaxine succinate205
Dexamethasone142
Dianeal392
Docetaxel113
Enbrel375
Ethanol117
Exjade156
Extraneal119
Fludara128
Fluorouracil126
Forteo423
Fosamax118
Geodon342
Gleevec132
Glucophage119
Humira500
Ibuprofen157
Imitrex138
Keppra117
Lamictal625
Lamotrigine236
Lantus196
Letairis148
Levaquin180
Lipitor313
Lucentis131
Lyrica340
Metformin hcl287
Methotrexate151
Metoclopramide121
Mirena509
Multaq169
Nexium209
Nplate122
Paxil295
Plan B One-Step152
Pradaxa733
Prednisolone162
Prednisone206
Rebif318
Remicade544
Remodulin462
Revlimid405
Rituximab166
Seroquel231
Simcor577
Simvastatin131
Solostar104
Sutent206
Synthroid258
Tiotropium bromide181
Tracleer263
Tysabri2,109
Valtrex138
Viagra100
Victoza1,125
Xalatan208
Xeloda125
Yasmin191
Yaz223
Zoloft102
Zometa137
Zyprexa125

Reaction terms in the reports

The table has the 89 reaction terms with 250 or more reports in February 2011. The rows are in order of name. One report can record more than one term.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Reaction terms that the drug reports of February 2011 record, in order of name
Reaction term (MedDRA) and plain meaningReports in the month
Abdominal discomfortstomach discomfort307
Abdominal painstomach or belly pain599
Abdominal pain upperupper stomach pain464
Alopeciahair loss299
Anaemialow red blood cells449
Anxietyanxiety805
Arthralgiajoint pain620
Astheniaweakness or lack of energy811
Atrial fibrillationan irregular heart rhythm292
Back painback pain471
Balance disorderproblems with balance254
Blood glucose increasedraised blood sugar reading495
Blood pressure increaseda raised blood pressure reading316
Cardiac arrestthe heart stopped404
Cardiac failure congestivecongestive heart failure477
Cardio-respiratory arrestthe heart and breathing stopped274
Cerebrovascular accidentstroke569
Chest painchest pain496
Chillschills or shivering255
Completed suicidedeath by suicide566
Condition aggravatedthe condition being treated got worse294
Confusional stateconfusion398
Constipationconstipation315
Convulsion443
Coughcough362
Deaththe patient died; cause not stated by this term2,004
Decreased appetitereduced appetite512
Deep vein thrombosisa blood clot in a deep vein250
Dehydrationdehydration337
Depressionlow mood902
Diarrhoealoose or frequent stools1,003
Dizzinesslight-headedness or unsteadiness1,074
Drug exposure during pregnancythe medicine was taken during pregnancy702
Drug ineffectivethe medicine did not work as expected2,256
Drug interactionan interaction between medicines416
Dysphagiadifficulty swallowing256
Dyspnoeashortness of breath1,136
Erythemaskin redness381
Falla fall769
Fatiguetiredness1,249
Feeling abnormalfeeling odd or not right481
Flushingsudden reddening or warmth of the skin414
Gait disturbancedifficulty walking498
Headachehead pain1,305
Hyperhidrosisexcessive sweating263
Hypersensitivityan allergic-type reaction333
Hypertensionhigh blood pressure491
Hypoaesthesianumbness388
Hypotensionlow blood pressure455
Inflammatory bowel disease260
Injection site painpain where the injection was given285
Insomniadifficulty sleeping573
Loss of consciousnesspassing out354
Malaisegeneral feeling of being unwell841
Memory impairmentmemory problems257
Multiple sclerosis relapsea flare of multiple sclerosis300
Muscle spasmsmuscle cramps397
Muscular weaknessmuscle weakness331
Myalgiamuscle pain391
Myocardial infarctionheart attack817
Nasopharyngitisa cold276
Nauseafeeling sick1,722
Neoplasm malignanta cancer, type not specified259
Oedema peripheralswelling of the legs, ankles or hands486
Overdosea dose above the recommended amount338
Painpain, site not specified1,069
Pain in extremitypain in an arm or leg556
Palpitationsawareness of the heartbeat288
Paraesthesiatingling or pins and needles419
Pneumonialung infection671
Product quality issuea problem with the product itself368
Pruritusitching640
Pulmonary embolisma blood clot in the lung336
Pyrexiafever793
Rashskin rash751
Renal failurekidney failure402
Renal failure acute342
Sepsisa severe body-wide response to infection307
Somnolencedrowsiness372
Suicidal ideationthoughts of suicide315
Syncopefainting277
Thrombocytopenialow platelets288
Tremorshaking447
Urinary tract infectionbladder or urinary infection336
Urticariahives356
Vision blurredblurred vision339
Vomitingbeing sick1,032
Weight decreasedweight loss577
Weight increasedweight gain401

Devices in the reports

The table has the 80 device pages with 50 or more reports in February 2011. The rows are in order of name. A device page with fewer reports is not in the table.

FDA says:

MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices.

Source: openFDA, Manufacturer and User Facility Device Experience. The site read the page on .

Device brand names that the device reports of February 2011 name, in order of name
Brand nameReports in the month
840 Ventilator50
Access 2 Immunoassay System89
Accu-Chek Aviva Test Strips146
Accu-Chek Comfort Curve Test Strips82
Accu-Chek Compact Test Drum100
Accu-Chek Multiclix50
Accu-Chek Spirit102
Acrysof58
Animas Insulin Infusion Pump323
Asku88
Attain Ability239
Attain Otw268
Attain Starfix60
Automated Pd Set W/Cassette4 Prong202
Bravo69
Capsure Sense69
CapSure SP104
Capsure Sp Novus114
Capsure Z Novus67
Capsurefix149
Capsurefix Novus808
Centra Bed52
Colleague Cx Triple Channel Volumetric Infusion Pump51
Colleague Cx Volumetric Infusion Pump Single Channel79
Colleague Single Channel Volumetric Pump Ce French50
Consulta88
Cypher Sirolimus-Eluting Coronary Stent83
Dextrus 413652
E Series Defibrillator56
Endeavor Sprint Rx Coronary Stent System122
Endopath Xcel Trocar53
Greenlight Addstat201
Heart Start XL76
HomeChoice Automated PD Set with Cassette101
Homechoice Cycler-Refurbished129
Infiniti Vision System Ozil56
Inratio137
Integrated Apd Set W/Cassette3 Prong105
Integrated Apd Set W/Cassette3-Prong90
LifeVest WCD 4000 System60
M Series168
Nucleus 24 Channel Cochlear Implant System51
Octrode Percutaneous Lead52
OmniPod Insulin Pump51
One Touch Ping Glucose Management System307
Ot Ping Meter242
Ot Ultralink Meter227
Paradigm Insulin Infusion Pump53
Paradigm Real-Time Insulin Infusion Pump250
Paradigm Real-Time Revel Insulin Infusion Pump72
Perclose Proglide 6f Suture Mediated Closure Smc System175
Power Pro Ambulance Cot112
Precision Test Strips446
Precision Xtra311
Precision?134
Promus Everolimus Eluting Coronary Stent System52
Pulse Gen Model 10257
Renal - Disposable181
Restore Ultra105
Screw-In75
Secure 3 Med/Surg Bed51
Sm204 M-Series W/Big Wheel90
Sprint82
Sprint Fidelis129
Sprint Quattro75
Sprint Quattro Secure540
Sprint Quattro Secure S132
Starclose Se Vascular Closure System83
Stealthstation S7 System50
Stealthstation Treon Treatment Guidance System127
Stenoscop146
Taxus Liberte Paclitaxel-Eluting Coronary Stent System94
Terumo Advanced Perfusion System 150
Terumo Cdi 500 Blood Parameter Monitor98
Totalcare205
Transtar Stretcher91
Ultracision Harmonic Ace54
Unicel Dxi 800 Access Immunoassay System124
Unknown Depuy Asr Hip115
Xience V Everolimus Eluting Coronary Stent System114

Cite this page

Reported Reactions. February 2011: adverse event reports received by FDA. https://reportedreactions.com/month/2011-02/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of . Reports received through .

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

The device counts come from the openFDA Device Adverse Event (MAUDE) bulk files, release of 23 Oct 2026. The files have the reports that FDA received through 30 Sep 2026. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

Can the count for February 2011 change?

Yes. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases. This page has the count of the openFDA release of 29 Oct 2026: 38,469 drug reports.

Does a month with many reports mean that something occurred in that month?

Not by itself. The date is the date on which FDA received the report, not the date of the event. FDA says:

Many factors can influence whether or not an event will be reported, such as the time a product has been marketed and publicity about an event.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

How does a person report an adverse event?

FDA runs MedWatch, a program that takes voluntary reports from health professionals, patients and consumers. The guide on how to report has the links.